Small Molecule Specific Run Acceptance, Specific Assay Operation, and Chromatographic Run Quality Assessment: Recommendation for Best Practices and Harmonization from the Global Bioanalysis Consortium Harmonization Teams Eric J. WoolfStuart McDougallElizabeth Thomas White Paper 25 June 2014 Pages: 885 - 893
G.L. Amidon, H. Lennernas, V.P. Shah, and J.R. Crison. A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of In Vitro Drug Product Dissolution and In Vivo Bioavailability, Pharm Res 12, 413–420, 1995—Backstory of BCS Vinod P. ShahGordon L. Amidon Commentary 25 June 2014 Pages: 894 - 898
Prodrug Applications for Targeted Cancer Therapy Irene GiangErin L. BolandGregory M. K. Poon Review Article 09 July 2014 Pages: 899 - 913
Next Generation Ligand Binding Assays—Review of Emerging Real-Time Measurement Technologies Stephanie FraserMark CameronMark Ware Review Article 25 July 2014 Pages: 914 - 924
Dashboard Systems: Implementing Pharmacometrics from Bench to Bedside Diane R. MouldRichard N. UptonJessica Wojciechowski Review Article 20 June 2014 Pages: 925 - 937
Biological Products for the Treatment of Psoriasis: Therapeutic Targets, Pharmacodynamics and Disease-Drug-Drug Interaction Implications Jie WangYow-Ming C. WangHae-Young Ahn Review Article 04 July 2014 Pages: 938 - 947
GATG Dendrimers and PEGylated Block Copolymers: from Synthesis to Bioapplications Ana Sousa-HervesRamon Novoa-CarballalEduardo Fernandez-Megia Review Article 09 July 2014 Pages: 948 - 961
Making the Most of Clinical Data: Reviewing the Role of Pharmacokinetic-Pharmacodynamic Models of Anti-malarial Drugs Julie A. SimpsonSophie ZaloumisJames M McCaw Review Article 24 July 2014 Pages: 962 - 974
Development of a Poly (lactic-co-glycolic acid) Particle Vaccine to Protect Against House Dust Mite Induced Allergy Vijaya B. JoshiAndrea Adamcakova-DoddAliasger K. Salem Research Article 01 July 2014 Pages: 975 - 985
Induction of Death Receptor CD95 and Co-stimulatory Molecules CD80 and CD86 by Meningococcal Capsular Polysaccharide-Loaded Vaccine Nanoparticles Ruhi V. UbaleRikhav P. GalaMartin J. D’Souza Research Article 01 July 2014 Pages: 986 - 993
A Mechanistic Pharmacokinetic Model Elucidating the Disposition of Trastuzumab Emtansine (T-DM1), an Antibody–Drug Conjugate (ADC) for Treatment of Metastatic Breast Cancer Brendan BenderDouglas D. LeipoldLena E. Friberg Research Article 11 June 2014 Pages: 994 - 1008
Population Pharmacokinetic Modeling of LY2189102 after Multiple Intravenous and Subcutaneous Administrations SĂ©bastien BihorelJill Fiedler-KellyEyas Raddad Research Article 11 June 2014 Pages: 1009 - 1017
Application of a Physiologically Based Pharmacokinetic Model Informed by a Top-Down Approach for the Prediction of Pharmacokinetics in Chronic Kidney Disease Patients Hiroyuki SayamaHiroaki TakuboMasahiro Iwaki Research Article 11 June 2014 Pages: 1018 - 1028
Diurnal Variation in P-glycoprotein-Mediated Transport and Cerebrospinal Fluid Turnover in the Brain Laura KervezeeRobin HartmanElizabeth C. M. de Lange Research Article Open access 11 June 2014 Pages: 1029 - 1037
Effects of Replacement of Factor VIII Amino Acids Asp519 and Glu665 with Val on Plasma Survival and Efficacy In Vivo Matthew P. KosloskiKrithika A. ShettySathy V. Balu-Iyer Research Article 17 June 2014 Pages: 1038 - 1045
An Electrically Tight In Vitro Blood–Brain Barrier Model Displays Net Brain-to-Blood Efflux of Substrates for the ABC Transporters, P-gp, Bcrp and Mrp-1 Hans Christian HelmsMaria HersomBirger Brodin Research Article 17 June 2014 Pages: 1046 - 1055
Lower Exposure and Faster Clearance of Bevacizumab in Gastric Cancer and the Impact of Patient Variables: Analysis of Individual Data from AVAGAST Phase III Trial Kelong HanJin JinDavid E. Allison Research Article Open access 19 June 2014 Pages: 1056 - 1063
Efficacious Intestinal Permeation Enhancement Induced by the Sodium Salt of 10-undecylenic Acid, A Medium Chain Fatty Acid Derivative David J. BraydenEdwin Walsh Research Article 25 June 2014 Pages: 1064 - 1076
Physiologically Based Absorption Modelling to Predict the Impact of Drug Properties on Pharmacokinetics of Bitopertin Neil ParrottDominik HainzlMeret Martin-Facklam Research Article 27 June 2014 Pages: 1077 - 1084
Predicting when Biliary Excretion of Parent Drug is a Major Route of Elimination in Humans Chelsea M. HoseyFabio BroccatelliLeslie Z. Benet Research Article 09 July 2014 Pages: 1085 - 1096
Simulation of Monoclonal Antibody Pharmacokinetics in HumansUsing a Minimal Physiologically Based Model Linzhong LiIain GardnerMasoud Jamei Research Article 09 July 2014 Pages: 1097 - 1109
Statistical Power Calculations for Mixed Pharmacokinetic Study Designs Using a Population Approach Frank KloproggeJulie A. SimpsonJoel Tarning Research Article Open access 11 July 2014 Pages: 1110 - 1118
Effect of Excipients on the Particle Size of Precipitated Pioglitazone in the Gastrointestinal Tract: Impact on Bioequivalence Masaru SugitaMakoto KataokaShinji Yamashita Research Article 29 July 2014 Pages: 1119 - 1127
Light Obscuration Measurements of Highly Viscous Solutions: Sample Pressurization Overcomes Underestimation of Subvisible Particle Counts Daniel WeinbuchWim JiskootAndrea Hawe Brief/Technical Note 17 June 2014 Pages: 1128 - 1131
Completeness Assessment of Type II Active Pharmaceutical Ingredient Drug Master Files under Generic Drug User Fee Amendment: Review Metrics and Common Incomplete Items Huyi ZhangHaitao LiLawrence X. Yu Regulatory Note 18 July 2014 Pages: 1132 - 1141